Role of extracorporeal membrane oxygenation in critically Ill COVID-19 patients and predictors of mortality.
Acute respiratory distress syndrome
COVID-19
SARS-CoV-2
critical care
extra corporeal membrane oxygenation
risk factors
Journal
Artificial organs
ISSN: 1525-1594
Titre abrégé: Artif Organs
Pays: United States
ID NLM: 7802778
Informations de publication
Date de publication:
Jun 2021
Jun 2021
Historique:
revised:
11
11
2020
received:
15
08
2020
accepted:
16
11
2020
pubmed:
26
11
2020
medline:
11
6
2021
entrez:
25
11
2020
Statut:
ppublish
Résumé
The role of extracorporeal membrane oxygenation (ECMO) in the management of critically ill COVID-19 patients remains unclear. Our study aims to analyze the outcomes and risk factors from patients treated with ECMO. This retrospective, single-center study includes 17 COVID-19 patients treated with ECMO. Univariate and multivariate parametric survival regression identified predictors of survival. Nine patients (53%) were successfully weaned from ECMO and discharged. The incidence of in-hospital mortality was 47%. In a univariate analysis, only four out of 83 pre-ECMO variables were significantly different; IL-6, PCT, and NT-proBNP were significantly higher in non-survivors than in survivors. The Respiratory Extracorporeal Membrane Oxygenation Survival Prediction (RESP) score was significantly higher in survivors. After a multivariate parametric survival regression, IL-6, NT-proBNP and RESP scores remained significant independent predictors, with hazard ratios (HR) of 1.069 [95%-CI: 0.986-1.160], P = .016 1.001 [95%-CI: 1.000-1.001], P = .012; and .843 [95%-CI: 0.564-1.260], P = .040, respectively. A prediction model comprising IL-6, NT-proBNP, and RESP score showed an area under the curve (AUC) of 0.87, with a sensitivity of 87.5% and 77.8% specificity compared to an AUC of 0.79 for the RESP score alone. The present study suggests that ECMO is a potentially lifesaving treatment for selected critically ill COVID-19 patients. Considering IL-6 and NT-pro-BNP, in addition to the RESP score, may enhance outcome predictions.
Identifiants
pubmed: 33236373
doi: 10.1111/aor.13873
pmc: PMC7753822
doi:
Substances chimiques
Biomarkers
0
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
E158-E170Informations de copyright
© 2020 International Center for Artificial Organs and Transplantation and Wiley Periodicals, LLC.
Références
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
ASAIO J. 2020 Jul;66(7):722-730
pubmed: 32317557
Am J Respir Crit Care Med. 2017 Feb 1;195(3):331-338
pubmed: 27513822
JAMA Intern Med. 2020 Sep 1;180(9):1152-1154
pubmed: 32602883
Anesthesiology. 2017 Apr;126(4):678-687
pubmed: 28212205
J Cardiothorac Vasc Anesth. 2020 Nov;34(11):3006-3012
pubmed: 32828653
Artif Organs. 2021 Jun;45(6):E158-E170
pubmed: 33236373
Perfusion. 2008 May;23(3):173-8
pubmed: 19029268
Lancet Respir Med. 2020 Nov;8(11):1121-1131
pubmed: 32798468
Lancet. 2020 Mar 28;395(10229):1033-1034
pubmed: 32192578
JAMA. 2020 Apr 28;323(16):1574-1581
pubmed: 32250385
Artif Organs. 2020 Sep;44(9):918-925
pubmed: 32516506
Artif Organs. 2021 Feb;45(2):189-190
pubmed: 32839961
ASAIO J. 2020 May;66(5):472-474
pubmed: 32243267
Pulm Circ. 2014 Jun;4(2):280-8
pubmed: 25006447
Crit Care. 2016 Nov 28;20(1):387
pubmed: 27890016
Front Neurol. 2018 Jul 06;9:548
pubmed: 30034364
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
N Engl J Med. 2018 May 24;378(21):1965-1975
pubmed: 29791822
Card Fail Rev. 2020 Jun 26;6:e17
pubmed: 32670617
Lancet Respir Med. 2019 Feb;7(2):163-172
pubmed: 30642776
Chest. 1995 Apr;107(4):1062-73
pubmed: 7705118
J Thromb Haemost. 2020 Apr;18(4):844-847
pubmed: 32073213
Minerva Cardioangiol. 2020 Oct;68(5):368-372
pubmed: 32336080
Intensive Care Med. 2020 May;46(5):846-848
pubmed: 32125452
Lancet. 2020 Oct 10;396(10257):1071-1078
pubmed: 32987008
ASAIO J. 2020 Jun;66(6):588-598
pubmed: 32358232
Perfusion. 2014 Mar;29(2):139-41
pubmed: 23887087
Lancet Respir Med. 2014 Aug;2(8):611-20
pubmed: 24853585
Chest. 1999 Mar;115(3):818-22
pubmed: 10084497
ASAIO J. 2020 Jul;66(7):707-721
pubmed: 32604322
JAMA Intern Med. 2020 Nov 1;180(11):1436-1447
pubmed: 32667668
JAMA. 2018 Dec 4;320(21):2251-2259
pubmed: 30347031
Ann Intensive Care. 2019 Jun 13;9(1):69
pubmed: 31197492
Int J Infect Dis. 2020 May;94:78-80
pubmed: 32251794
Anaesthesia. 2020 Aug;75(8):997-1001
pubmed: 32319081
AJNR Am J Neuroradiol. 2020 Nov;41(11):2009-2011
pubmed: 32855187
Lancet Respir Med. 2020 May;8(5):475-481
pubmed: 32105632
Crit Care Med. 2020 Sep;48(9):1289-1295
pubmed: 32427613